Results 11 to 20 of about 5,409,033 (241)

Transitional cell carcinoma of the nasolacrimal sac

open access: yesClinical Ophthalmology, 2009
Rushmia Karim, Raf Ghabrial, Betty LinUniversity of Sydney, Concord Repatriation General Hospital, Sydney, New South Wales, AustraliaAbstract: Tumors in the lacrimal sac are rare yet important due to their malignant and potentially lethal outcomes if ...
Rushmia Karim, Raf Ghabrial, Betty Lin
doaj   +1 more source

Thrombus-like Tumor of Renal Cell Carcinoma Mimicking Transitional Cell Carcinoma of Kidney: A Case Report [PDF]

open access: yesUrology Case Reports, 2017
Renal cell carcinoma (RCC) is the most common malignancy of the kidney. It is not commonly form tumor thrombus in the ureter or renal pelvis. A 29-year-old woman presented with asymptomatic gross hematuria. Contrast CT study revealed a tumor suspected to
Dyandra Parikesit   +5 more
doaj   +2 more sources

Primary Transitional Cell Carcinoma of the Fallopian Tube [PDF]

open access: yesOnline Journal of Health & Allied Sciences, 2012
Primary carcinoma of the fallopian tube is a rare entity that accounts for 0.2-0.5% of all gynecologic malignancies, and most are discovered during or after surgery.
Kavita Mardi, Vijay Kaushal
doaj   +1 more source

Canine urethral transitional cell carcinoma [PDF]

open access: yes, 2003
The following case report describes the presentation and diagnostic evaluation of a 6-year-old spayed female mixed breed dog, with a 1.5-month history of dysuria, that was referred to the Small Animal Oncology Service at Cornell University's College of
Dampf, Melissa
core   +6 more sources

Surgical management for upper urinary tract transitional cell carcinoma [PDF]

open access: yes, 2011
Background Upper tract transitional cell carcinomas (TCC) are uncommon and aggressive tumours. There are a number of surgical approaches to manage this condition including open radical nephroureterectomy and laparoscopic procedures.
El-Mokadem, Ismail   +11 more
core   +1 more source

Mycotic aortic aneurysm formation following intravesical BCG treatment for transitional cell carcinoma of the bladder. [PDF]

open access: yesBMJ Case Rep, 2021
Mycotic aneurysms are rare and if left untreated, can have devastating outcomes. In this case, a 72-year-old man presented to hospital with fevers, night sweats and abdominal pain.
Flynn D   +5 more
europepmc   +2 more sources

A cell line derived from BBN (N-butyl-N-[4-hydroxybutyl]-nitrosamine)-induced rat bladder cancer: establishment and scanning electron microscopic cell surface characteristics [PDF]

open access: yes, 1978
This research was performed to establish a cell line from experimental bladder tumor and to discuss the biological characteristics of the cell line so established. Tissue cultures of epithelial cells were derived from a rat bladder cancer induced by BBN.
Nishi, Mitsuo
core   +1 more source

Schistosomiasis and Urinary Bladder Cancer in North Western Tanzania: A Retrospective Review of 185 Patients. [PDF]

open access: yes, 2013
Worldwide, cancers of the urinary bladder are well known to be associated with environmental chemical carcinogens such as smoking and occupational exposure to polycyclic aromatic hydrocarbons.
Chalya, Philipo L   +5 more
core   +1 more source

Modulatory effects of T-cadherin on cell behavior and growth factor receptor activity in carcinoma cells [PDF]

open access: yes, 2014
Cancer is a major health problem. Epidermal growth factor receptor (EGFR) pathway plays an important role in cancer progression. EGFR-targeted anti-cancer drugs are being developed to improve anti-cancer therapy.
Maslova, Kseniya
core   +1 more source

The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo [PDF]

open access: yes, 2008
Histone deacetylase (HDAC) inhibitors represent a promising class of antineoplastic agents which affect tumour growth, differentiation and invasion. The effects of the HDAC inhibitor valproic acid (VPA) were tested in vitro and in vivo on pre-clinical ...
Eva Juengel   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy